A Dose Determination Study of Chinese Herbal Medicine for Functional Constipation
Launched by HONG KONG BAPTIST UNIVERSITY · Mar 6, 2006
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Functional constipation (FC) is a common complaint in clinical practice, with the estimated prevalence 14.3% in Hong Kong, as nearly affecting 1 million Hong Kong People in different extent. It is comparable with western population, which is 15% in North America. By the definition of Rome II criteria, FC comprises a group of functional disorders, which presents as persistent difficult, infrequent or seemingly incomplete defecation.
Constipation is often perceived to be benign, easily treated condition with short-term treatment being relatively straightforward. However, the fact is the mana...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of functional constipation with Rome II criteria
- • General stool type belongs to Type 1 to 4 according to Bristol Stool Form Scale
- • Complete spontaneous bowel movement≦2 movements per week
- Exclusion Criteria:
- • Anti-diarrhoeal therapy
- • Drug-induced constipation
- • Medical history of important bowel pathology, such as inflammatory bowel disease, congenital or acquired megacolon / megarectum
- • Medical history of previous abdominal surgery
- • Taking chronic medications that contain any kind of herbs, mineral, or specific vitamin supplements
- • Medical history of carbohydrate malabsorption, hormonal disorder, cancer, diabetes mellitus, hypothyroidism, asthma, renal impairment and/or any other serious diseases
- • History of laxative abuse
- • History of allergy to Chinese herbal medicine
- • Psychiatric or addictive disorders
- • Pregnancy or breast-feeding
- • Any other serious diseases
About Hong Kong Baptist University
Hong Kong Baptist University (HKBU) is a leading academic institution dedicated to advancing research and innovation in health sciences. With a strong emphasis on interdisciplinary collaboration, HKBU conducts clinical trials that aim to enhance medical knowledge and improve patient outcomes. The university is committed to adhering to the highest ethical standards and regulatory requirements, ensuring the integrity and reliability of its research efforts. Through its robust research framework and skilled faculty, HKBU strives to contribute significantly to the fields of medicine and healthcare both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Patients applied
Trial Officials
ZhaoXiang Bian, PhD
Principal Investigator
Hong Kong Baptist University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials